EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation

Tracey G Simon iD, Daniel E Singer iD, Yichi Zhang iD, Julianna M Mastrorilli, Alexander Cervone, Elyse DiCesare, Kueiyu Joshua Lin iD

Annals of Internal Medicine · 2024

DOI: 10.7326/m23-3067 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Internal Medicine, 2024. Verfasst von Tracey G Simon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; Division of Gas…. Hauptthemen laut MEDLINE: Warfarin, Pyridones, Atrial Fibrillation, Rivaroxaban. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinPyridonesAtrial FibrillationRivaroxabanPyrazolesAnticoagulantsLiver CirrhosisFactor Xa InhibitorsHemorrhageHumansMaleFemaleAgedUnited StatesPropensity ScoreMiddle AgedIschemic StrokeStrokeCohort StudiesEmbolism

Substanzen

WarfarinPyridonesapixabanRivaroxabanPyrazolesAnticoagulantsFactor Xa Inhibitors

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; Division of Gastroenterology and Hepatology, Department of Medicine, Massachusetts Ge…
  • Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (D.E.S.).
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Y.Z., J.M.M., A.C., E.D.).
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, B…

ORCID-Profile: Tracey G Simon, Daniel E Singer, Yichi Zhang, Kueiyu Joshua Lin

Förderung

  • NIA NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Simon, T. G., Singer, D. E., Zhang, Y., Mastrorilli, J. M., Cervone, A., DiCesare, E., & Lin, K. J. (2024). Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation. Annals of Internal Medicine. https://doi.org/10.7326/m23-3067

Vancouver

Simon TG, Singer DE, Zhang Y, Mastrorilli JM, Cervone A, DiCesare E, et al. Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation. Annals of Internal Medicine. 2024. doi:10.7326/m23-3067

BibTeX
@article{Simon2024,
  author = {Simon, Tracey G and Singer, Daniel E and Zhang, Yichi and Mastrorilli, Julianna M and Cervone, Alexander and DiCesare, Elyse and Lin, Kueiyu Joshua},
  title = {Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation},
  journal = {Annals of Internal Medicine},
  year = {2024},
  doi = {10.7326/m23-3067}
}
Kostenlos starten →